Between the billboards featuring drag superstars and endorsements by the likes of Gwyneth Paltrow, it’s hard to miss Cann. Since the weed drink brand launched in 2019, it’s taken the drinkables market by storm, selling over two million cans in just two years.
Until Cann’s 2.5-milligram cans came on the scene, the vast majority of beverages on dispensary shelves had a THC content of 10 to 100 milligrams per bottle. For a low-dose consumer like myself, that puts most weed drinks out of reach — despite portioning out a tablespoon of weed drink at a time, which was not an ideal user experience, to say the least. And don’t get me started on the flavor of first-generation weed drinks. Let’s just say it was rough.
Cann, by contrast, promises to go toe-to-toe with your favorite craft cocktails, ideally replacing the role of alcohol in your life altogether. Cann’s ability to make that kind of promise is partly thanks to its use of SōRSE Technology, the number-one supplier of water-soluble THC and CBD.
Between the celeb endorsements, water-soluble cannabinoids, and craft cocktail mentality, Cann should be one of the best weed drinks on the market today. But do the drinks actually live up to the hype? I tried Cann’s Grapefruit Rosemary and Lemon Lavender social tonics to find out.
Right away, you’ll notice Cann’s packaging is leagues ahead of most weed brands — drinkable or otherwise. The cans are not just beautiful with monochromatic, pastel color schemes and modern line art; it’s also exceedingly informative. The dose of 2 milligrams THC and 4 milligrams CBD per can is clearly labeled on the front of each drink. On the back, you can find gorgeously displayed nutritional information, a cute dosing tip, and buzzwords we all know and love like “non-GMO” and “no stevia.”
Size-wise, each can of Cann holds eight fluid ounces and is roughly the same size and shape as a mini can of Coke. The small drink size might seem like a scheme to up the adorable factor even more (they really are adorable), but it makes sense from a practical standpoint, too. How many sparkling waters have you started only to abandon it halfway through because it got warm and lost its fizz? The small can size circumvents this problem.
Can you tell I love the design of these drinks? Because I love the design of these drinks.
I first tried the Grapefruit Rosemary Cann. I have to start by saying I have high standards for grapefruit-flavored drinks. While it seems like it should be a simple flavor to nail, I’ve gone through countless citrusy sodas that are too sharp, too sweet, or leave behind a disappointing chemical aftertaste. The grapefruit flavor in this drink is perfectly bright and fresh, while the rosemary offers just enough earthiness to balance it out. It’s not nearly as sweet as a traditional soda, but just sweet enough to distinguish itself from flavored sparkling water. I would perhaps appreciate more bubbles in my Cann, but extra-fizzy sparkling water is simply my personal preference.
As for the Lemon Lavender Cann, the only way I can describe the flavor is fancy lemonade for grown-ass adults. It is herbal without tasting like soap and lemony without being overly acidic. I’m always so disappointed when I order a fancy, fruity cocktail only to have sickly sweetness overpower all the other flavors. Cann is able to strike that perfect balance of sweet enough to suck it down but refined enough to want to savor it.
With 2 milligrams of THC and 4 milligrams of CBD per can, you might not expect to feel much from these petite drinks. I, however, am a low-dose stoner. I tap out at 5-milligram gummies and can barely smoke a mini-joint by myself without waxing poetic about aliens for hours. So, 2 milligrams of THC is my happy place.
I started by sipping one can casually over the course of a half-hour. Right away, I could feel a lovely, subtle buzz that sustained itself and lasted for a little more than an hour. I could’ve easily had another Cann without feeling too high to hang in a big group of people, but it was also nice to know I could still get a significant vibe from just one.
I attribute the surprising effectiveness of one can to the presence of CBD in the mix. The entourage effect may still be up for debate, but I personally feel a more complex high when more than one cannabinoid is present, which was certainly the case here.
Overall, the experience was lovely. After trying both Cann flavors in a few different scenarios — with people, without, at home, and in a lively setting — it occurred to me that self-titrating is a game-changer when it comes to edible weed. You can sip a little at a time, slowly dosing yourself and easing into a high. As much as I love gummies, you can only eat the whole thing and wait for the whole high to hit you at once. It’s the difference between taking a shot of vodka and sipping a vodka cocktail over the course of an hour — neither choice is bad, necessarily, but they’re very different speeds.
I can easily see myself taking a six-pack of either the Grapefruit Rosemary and Lemon Lavender flavors to a picnic hang, house party, or game night instead of a bottle of wine. I can also see myself bringing both. It’s exciting to have the option to reduce my alcohol consumption without giving up the social and ritualistic aspects about it that I enjoy.
If you need at least 10 milligrams of THC to feel a modicum of a buzz, this is not the weed drink for you. I recommend Cann drinks to literally anyone else (21 and older and in a legal state, of course) because they are pretty much perfect in every way. I’m mad I didn’t invent these drinks myself because it’s genius, but then again, I’m glad I didn’t have to put in all the work of creating a new product from scratch. Instead, I get to sip the fruits of other geniuses’ labor and be glad I’m living in an era of legal weed drinks.
Featured image courtesy of Cann/Weedmaps
I sometimes wonder if people will ever stop asking me, “Does CBD actually work?” My guess is probably not, seeing how, like all cannabis compounds, CBD’s efficacy is dependent on a) an individual’s genetic makeup and predisposition, and b) whether or not the product they’ve tried actually contains the amount of CBD advertised. In an industry rife with cheap CBD imitators and perpetual cash-grab attempts, encountering a CBD product that works, and really works, feels like a personal victory.
For me, taking Willie’s Remedy CBD Coffee and Tea for a spin felt like one of those personal victory moments. The canna-beverage market is still in a relative state of infancy. It seems like only in the last year or so that a few choice beverage brands have become synonymous with potency and reliability.
CBD can be tricky because if you’re taking it, you want to be able to feel a definite effect without necessarily feeling stoned or even sleepy. My past experience with cannabis-infused coffee and tea is somewhat limited, but if I’ve ever had frustration with either, it’s that the difference wasn’t quite noticeable enough for my liking. So let’s dive into these hot drinks and see how they deliver.
The CBD sister-brand of Willie Nelson’s Willie’s Reserve cannabis, Willie’s Remedy specializes in full-spectrum hemp-infused coffee, tea, tincture, and topical balm. For this review, I’ll be looking at Willie’s Remedy Medium Roast Coarse Ground Coffee, Peppermint Tea Pyramid Bags, and Chamomile Tea Pyramid Bags.
Willie’s Remedy coffee comes in vibrant, brown paper bags with a label that emulates that old-fashioned, “General Store” coffee vibe, with a clear display of CBD content in milligrams (250 milligrams, to be precise) and the signature Willie phrase “Count Your Blessings Daily.” Willie’s tea bags come in round tins of 16 bags with 200 milligrams CBD per package — making for an approximate total of 12.5 milligrams per bag — also prominently displayed on the front label.
Celebrity-backed CBD companies are a dime a dozen at this point, and depending on which ones you’ve tried, your patience may vary already. Maybe I’m just letting my personal taste influence my first impression a little too much here, but I find the presentation of Willie’s Remedy not only to be aesthetically appealing but denotes a quality and authenticity that I’d expect from something that bears the Redheaded Stranger’s name.
And I’m no coffee expert, but the quality and strength of the smell when I opened my coffee bag far surpassed the aroma of the typical stuff I pick up from Trader Joe’s.
Medium Roast Coarse Ground Coffee
According to Willie’s Remedy, its coffee is “carefully selected and roasted, then infused with organically grown, full-spectrum hemp oil from independent US farmers.” As reported by The Spoon, hemp oil is applied directly to the beans immediately after roasting, which is intended to get a proper distribution of hemp throughout the beans and result in a richer flavor and effect in the final product.
Even in coarse ground form, my Medium Roast Willie’s coffee had a vibrant, multidimensional flavor that I noticed immediately. As I mentioned earlier, I’m no coffee expert, but for anyone whose relationship to coffee is primarily utilitarian but not enough to shy away from higher quality, I can’t imagine a cup of Willie’s Remedy being a let-down. I had hoped that I’d taste the hemp extract so I’d know for sure it was there, but ultimately the effects did a fine job of letting me know without affecting the taste of the coffee.
Happy to report that this cup ‘o joe absolutely delivers on its promised “harmony of focus from the caffeine plus calm from the hemp.” At first I thought it might’ve been just a placebo effect, but then I checked with a buddy of mine who happened to have had a cup over at my place as well. We both found that we’d been sufficiently energized and moderately soothed without feeling virtually any of the typical coffee jitters.
For my first cup of Willie’s CBD coffee, I held off for a little longer than I usually do after waking up, mostly to make sure I didn’t just chug it down by reflex and miss out on a fuller sense of how it made me feel. Most mornings I don’t eat much breakfast, and when I do, it’s usually to avoid making myself sick with coffee on an empty stomach. Against my better judgment, I forewent breakfast with my first cup of Willie’s Remedy but found my stomach felt just fine, even after a second cup.
I also felt my creative juices flowing pretty immediately, and on a sharper level than usual. I had energy, for sure, but I also had focus and creative drive, and I could feel a tangible difference in the way my thoughts coalesced. I don’t know what you call an experience like that if not holistic.
Peppermint & Chamomile Teas
Willie’s Remedy CBD tea is comparable in effect, as well as contrasting in flavor and overall experience, to Willie’s coffee. If there’s a place in your morning or daytime routine for tea, both the peppermint and chamomile teas offer an enriching sensory experience that can add vibrant dimensions to your day.
Willie’s peppermint tea is both soothing and invigorating in all the ways you’d hope. For some people, especially in America, tea will always be a hard sell, but this peppermint tea contains a rich, sweet flavor that’s appropriately earthy without just tasting earthy. There’s an immediate jolt to it that’s great for a morning or afternoon pick-me-up.
The chamomile tea is silky-smooth and will please anyone who likes to cozy up and sink into tranquility with a hot cup of chamomile with honey.
I’ll spare you the details of the night before I tried Willie’s peppermint tea, but I will say with total confidence that it’s great for helping with a hangover, especially if you’re not a coffee person. And as I already mentioned, its holistic, pick-me-up quality makes it enormously effective in setting a welcome mood for the day, potentially boosting productivity without sending you into an uncomfortable, caffeinated frenzy.
The same can be said for Willie’s chamomile tea, only with less immediate invigoration that comes with the peppermint. Though still enlivening in terms of focus and creativity, the chamomile put me on an even-keeled register that helped me stay calm and collected throughout the day.
As a connoisseur who’s sampled plenty of CBD products — some good, some bad, and many that are just ok — I was blown away by the overwhelming sense of cool, collected calm with a moderate boost of energy that both these teas provided. Assuming the CBD is distributed evenly, there were about 12.5 milligrams of CBD per tea bag — not a heavy amount but not necessarily a lightweight 5-milligram deal either. They set a tone, mood, and flavor to my mornings that couldn’t have been more conducive for completing daily tasks as well as stopping to enjoy the vibes of my surroundings.
For lifelong stoners, the impulse to turn every cannabis product into a hyper-capitalist productivity booster in the age of legalization and mainstream acceptance can be a bit of a downer. However, in the case of Willie’s Remedy coffee and tea, there’s a legitimate opportunity to curb anxiety, stress, and caffeine jitters while infusing the experience with just enough tranquility to effectively help one find peace through times when “getting shit done” is a necessity.
If you’re a coffee person, but you need something to balance out the jitters, Willie’s Remedy is more than worth a shot. If you’re looking for holistic ways to incorporate CBD (that actually works) into your daily routine, Willie’s Remedy tea is an excellent place to start.
Featured image by Willie’s Remedy/Weedmaps
The post We tried it: Willie’s Remedy CBD coffee & tea review appeared first on Weedmaps News.
I could be way off here, but I’ve noticed an interesting phenomenon of fatigue proliferating across a variety of industries. In Hollywood, for example, even the biggest superhero movies are underperforming at the box office — first and foremost because of the pandemic, but also because your average audience member has a wicked case of superhero fatigue. In the cannabis industry, it seems among consumers and industry insiders alike, there’s a nagging sense of edible fatigue out there.
People are tired of the same old super-sweet snacks and subpar gummies, and they’re ready for a higher quality edible cannabis experience. But here’s the thing: as the edible market gets more and more diverse in its arsenal of product categories, I think there’s going to be a renewed interest in edible “treats” that people can incorporate into their consumption habits with greater deliberation and specificity.
If any of this resonates with you, and you’re still looking for a convenient, tasty, and appropriately sweet edible that offers a well-rounded high, Cheeba Chews‘ new line of caramel and chocolate taffy might be for you. For this review, I’ll be trying Cheeba’s Trifecta and Sleepy Time taffy chews.
Going on a decade now, Cheeba Chews have been a well-respected staple of the cannabis edibles market. Born in Boulder, Colorado, from founder James Howler in 2009, Cheeba Chews came about out of a desire to make edible lab testing more accountable and provide an imminently accessible edible that delivers on quality and consistency.
The new additions to the Cheeba Chews line — the Trifecta caramel taffy with a 1:1:1 CBG:CBD:THC ratio and the Sleepy Time chocolate taffy with a 2:1 THC:CBN ratio — come in sleek yet inviting packs of 20 bite-sized chews. The gold-tinted aesthetic of these packages brings to mind the elegant, understated luxury vibe of dark chocolate treats like Riesen’s or Skor bars. You’ll find batch information and THC content displayed on the back of the outer wrapper, and the front label includes instructions for accessing the separately packaged chews in the breakable plastic tray inside.
Individual chews come in two trays of 10 stacked on top of one another. Each piece snaps off from the rest of the tray pretty easily, and the lining is accessible and easy to peel off. And because the tray was easy to work with, I walked away from the unpackaging experience with a sense of appreciation for the precision and security of the way these chews are contained.
Trifecta Caramel Taffy
With most edibles, you get a mix of vague cannabis extract flavor with whatever central ingredients make up the product. Sometimes these flavors clash. Other times they blend well. Luckily, Cheeba Trifecta chews are of the latter variety. These bite-sized caramel taffy chews give a taste that blends smoothly with the inherent cannabis flavor, and as it melts in your mouth, you get an assurance that it is cannabis-infused, as advertised, while delivering a noticeable caramel taste that isn’t overly sweet.
If you’re a first-time consumer of Cheeba Chews, the company recommends starting with one chew, then giving yourself ample time to observe the effects before taking more. Because I’m a regular consumer of flower and edibles, I took on the risk of taking two chews to get a decent sense of what a less-experienced consumer might feel after one. After about 50 minutes, the effects came on strong, but not too strong, and there was no mistaking them.
There was also no mistaking the uniqueness of the chew’s intended 1:1:1 experience of 5 milligrams THC, CBD, and CBG, which was designed to offer a “mild psychoactive experience,” as well as “promote a positive state of mind.”
I definitely enjoyed the even mix of mild psychoactivity and palpable body relaxation, feeling sufficiently stoned and also just calm, relaxed, and full of thoughts for a good portion of the day. I was also kind of surprised by this chew’s mood-boosting quality, which seemed to carry over well after the other psychoactive effects had worn off.
Sleepy Time Chocolate Taffy
The Sleepy Time chocolate taffy has a comparably enjoyable melt-in-your-mouth texture to the caramel chew, only with a decidedly different flavor experience. The chocolate taste was sweet but earthy, blending even more synergistically with the chew’s plant-based ingredients.
After sampling the Trifecta taffy and being more than satisfied with its effectiveness, I decided to try only one Sleepy Time chew in the evening to test out its effectiveness as a sleep aid. These chews offer a 2:1 THC:CBN ratio with 5 milligrams THC and an added dose of melatonin, so I figured if these things worked, one chew would probably do the trick for me. In a similar fashion to the Trifecta taffy, it only took about 50 minutes to get the full effect.
Considering my previous Cheeba experience, I sampled a Sleepy Time chew fairly late in the evening, around 10:15 p.m., in preparation for the effects to hit around the time I wanted to drift off to sleep. Once again, around 50 minutes later, I noticed myself starting to drift off a bit. Then the mild stoniness slowly permeating my head also became apparent. After another 15 minutes of getting ready for bed, my head hit my pillow and I was out in no time.
A lot of edibles, especially if I take them at night, leave me with a light weed hangover the next day. With this Cheeba Chew, I woke up feeling pretty damn refreshed and not only no worse for wear, but in a decent mood — a rarity for mornings around my house.
Quality and consistency are the things Cheeba Chews have hung its hat on from the beginning. The brand’s latest confections tell me it can continue to do so. If you’re suffering edible fatigue, these convenient Cheeba Chews offer a winning texture, flavor, and delivery method for precise consumption and streamlined, holistic effects. Whether you want to feel stoned, happy, or appropriately sleepy after a long day, Cheeba Chews may be well worth your time.
Featured image courtesy of Cheeba Chews/Weedmaps
The post We tried it: Cheeba Chews’ new caramel & chocolate taffy appeared first on Weedmaps News.
Legacy market players were making cannabis products before legalization was a twinkle in Justin Trudeau’s eye.
The post Once illegal brands are taking over the legal cannabis market appeared first on Leafly.
Federal prosecutors can now decide whether to enforce federal law prohibiting marijuana, even in states where marijuana has been legalized. Here’s a look at the implications of the change.
According to a report by the Associated Press, United States Attorney General Jeff Sessions announced this morning that he has rescinded an Obama administration federal policy that directed prosecutors and law enforcement to not prioritize interference with states that legalized marijuana.
That policy, the Cole Memo, was a memorandum originally drafted by former U.S. Attorney General James M. Cole in 2013. Published through the Department of Justice, the document indicated that federal law enforcement would not crackdown on state-legal adult use marijuana operations, provided officials made efforts to prevent the distribution of marijuana to minors, criminal enterprises, and to states where it was illegal.
Sessions one-page memo to federal prosecutors announcing the policy being rescinded comes only days after retail marijuana shops opened in California, and indicates that Sessions does have plans to aggressively enforce federal law and stand in the way of states that legalize marijuana.
“In deciding which marijuana activities to prosecute under these laws with the Department’s finite resources, prosecutors should follow the well-established principles that govern all federal prosecutions,” Sessions wrote in the memo.
Months ago Sessions acknowledged the Obama-era hands-off policy was still in place, but quickly reiterated that marijuana “still remains illegal with regard to federal purposes.” Sessions is a staunch cannabis opponent. In the past, he compared marijuana to heroin and blamed it for spikes in violence, despite these claims being based on fear and not fact.
The announcement by Sessions was quickly criticized by advocates and lawmakers, including Colorado Republican Sen. Cory Gardner, who said in a tweet that the move by the Justice Department “has trampled on the will of the voters.”
This Is What the Change Could Mean for Legal Marijuana
Sessions’ new policy will give U.S. attorneys throughout the nation to decide whether to use federal resources to devote to marijuana enforcement.
Enforcement of federal laws against recreational marijuana could jeopardize billions in projected revenue nationwide. A recent report projected that the U.S. legal cannabis market would balloon from $6.7 billion in 2016 to $24.5 billion by 2025.
This would also directly cut into the $1.4 billion in tax revenue generated by states where marijuana has been legalized.
Colorado has used its cannabis tax dollars since legalizing recreational marijuana in 2012 to fund mental health clinics, provide college scholarships, as well as repair roads, schools, and fund Medicaid. A majority of Washington’s marijuana tax revenue goes to education and youth programs, substance abuse prevention and treatment, community health centers, and the state’s share of Medicaid.
A federal crackdown could also put a significant wrench in the marijuana industry’s growing job sector, which was on track to surpass the number of people employed by manufacturing, utilities, and government industries. A recent market report from Marijuana Business Daily calculated that the nation’s cannabis industry has already generated 165,000 to 230,000 full- and part-time jobs, up from the 100,000 to 150,000 jobs in place the year before.
Sessions’ memo may not affect states where medical marijuana is legal. A congressional amendment, the Rohrabacher-Farr Amendment, prohibits the Justice Department from interfering with medical marijuana programs in the 29 states where medical cannabis has been legalized. Earlier this year, Sessions sent a letter to congressional leadership requesting that they not continue the amendment. The amendment was just extended to at least January 19.
What Could the Memo Mean for Medical Marijuana, Inc.?
Medical Marijuana, Inc. and the federally legal hemp cannabidiol (CBD) market are unaffected by the policy change announcement by Sessions.
CBD hemp oil is excluded from the federal Controlled Substances Act. Customers, shareholders, and the public can be reassured that hemp-based CBD products are unaffected by recreational laws or current political stances.
Keep up with the Cannabis Industry
The post SESSIONS RESCINDS FEDERAL POLICY THAT PROTECTS STATE-LEGAL MARIJUANA appeared first on Medical Marijuana, Inc..
Local artists from Massachusetts talk about their their creative process and show off awesome custom rolling trays.
The post Massachusetts artists represent their state with weed rolling trays appeared first on Leafly.
In a September 14 press release, Wesana Health Holdings Inc. announced its commitment to fund $1.5 million to assess the efficacy of Multidisciplinary Association for Psychedelic Studies (MAPS) MDMA-assisted therapy to treat traumatic brain injury (TBI).
The funding will allow MAPS Public Benefit Corporation (MAPS PBC) to activate a team to evaluate the scope of the lack of resources needed for TBI treatment.
“Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. What Daniel and his team are doing is in line with MAPS’ ethics, mission, values and scientific rigor, and we believe together, MAPS and Wesana can bring much needed help to the massively underserved TBI population. Data collected from MAPS-sponsored Phase 3 clinical trials suggests that MDMA-assisted therapy appears promising in the treatment of TBI. Consistent with our mission, we seek to investigate treatments for affected patients who can be helped by MDMA—this is an important step in that direction” said MAPS Executive Director Rick Doblin, Ph.D.
Lately, MAPS research zeroed in on MDMA-assisted therapy for PTSD. The first of two Phase 3 trials demonstrated a “clinically significant reduction” in PTSD symptoms for 88 percent of participants.
Existing research suggests that MDMA improved cognitive function in mice with minimal TBI. Like PTSD, TBI can have a profound impact on mental health. Research indicates that there is a disproportionate impact for people of color.
Over 6.2 million Americans are estimated to have chronic TBI-related disabilities, not to mention the symptoms that are more mild but also impact daily life. Nearly 414,000 Iraq and Afghanistan Veterans had a TBI.
“The work MAPS has done for more than 35 years with regulators and clinical researchers to navigate the rigorous and necessary FDA approval process for MDMA therapeutic use has positioned psychedelic-assisted therapy on the precipice of national—and global—acceptance,” Daniel Carcillo, CEO of Wesana Health said. “The millions of people afflicted with PTSD may soon have access to MDMA therapy, and we believe the millions suffering from TBI may experience similar relief in the future.”
This collaboration between MAPS and Wesana will boost MAPS PBC’s research timelines and provide additional support for further research, advocacy, education and equitable access to MDMA-assisted therapy treatments.
Wesana outlined five key goals:
- Gain expertise and information to design psychedelic-assisted therapy programs for TBI and improve the Wesana timeline and path to market for its treatments
- Explore obtaining an exclusive commercial license to use MDMA for the treatment of TBI
- Evaluate the viability of revenue share agreements between the organizations
- Adapt MAPS’ equitable access research projects to develop a meaningful patient access program
- Fund associated research, administered by MAPS PBC, with additional capital
Beyond MDMA, MAPS Pushes Psychedelic Research Forward
MAPS is pushing forward research on a number of psychedelics with potential in medicine. On August 10, MAPS was awarded a $12,979,050 grant from the state of Michigan to fund a study on post-traumatic stress disorder (PTSD) and cannabis.
According to Dr. Sue Sisley, President of the Scottsdale Research Institute and longtime cannabis researcher, this new study is sorely needed in the community.
The grant comes from Michigan’s 2021 Veteran Marijuana Research Grant Program, and is funded by the state’s recreational cannabis taxes. With a goal of determining the “the efficacy of marijuana in treating the medical conditions of United States armed services veterans and preventing veteran suicide.”
The Michigan grant makes it the second clinical trial to give cannabis medicine or placebos to participating military veterans, and according to the Chief Science Officer of the MAPS Public Benefit Corporation, Berra Yazar-Klosinki, PhD, the first trial was a great success.
Now, with the commitment from Wesana Health, MAPS’ research on MDMA can accelerate as well.
The post Study on MDMA for Traumatic Brain Injury Boosted By $1.5M Donation appeared first on High Times.
The Missouri Department of Health and Senior Services said Thursday that it had initiated the second required transfer of revenue from the state’s new medical marijuana program to the Missouri Veterans Commission.
The total amount of funds transferred is $6,843,310, more than the first transfer in September of last year, which came to $2,135,510.
The transfer of the funds is required under the constitutional amendment legalizing medical marijuana that Missouri voters approved in 2018. A provision under the amendment, which is now known as Article XIV, requires “that fees and taxes collected by [Missouri Department of Health and Senior Services] for the medical marijuana program, less operational expenses, should be transferred to the [Missouri Veterans Commission] for health and care services for military veterans,” the agency said in a press release on Thursday.
The department said it has “collected fees related to facility and patient licensing,” and that “Article XIV states that medical marijuana sold in licensed dispensaries will be taxed at a rate of 4%.”
Article XIV states that the remainder of medical marijuana funds must go to the veterans commission “for health and care services for military veterans, including the following purposes: operations, maintenance and capital improvements of the Missouri veterans homes, the Missouri service officer’s program and other services for veterans approved by the commission, including, but not limited to, health care services, mental health services, drug rehabilitation services, housing assistance, job training, tuition assistance and housing assistance to prevent homelessness.”
Missouri voters overwhelmingly approved the amendment legalizing medical cannabis in the state, passing the measure by a margin of 66-34 percent.
The first dispensaries in the state opened their doors to customers in October of 2020.
Since then, the program in the Show Me State has boomed. The Missouri Department of Health and Senior Services said earlier this month that the medical cannabis program has grown to include a little more than 140 dispensaries––still shy of the 192 required by the amendment––and the industry employs roughly 5,000 people.
By the end of July, the department said that sales for medical marijuana had eclipsed $91 million.
“The amendment that was voted on said that we should open the minimum number at least, which was 192 dispensaries,” said Lyndall Fraker, director of the section of medical marijuana with the Missouri Department of Health and Senior Services. “As of today, we have 142 open. We’ve done the math, and based on the number of quantities that each patient can purchase each month, how much product it would take to serve the patient base, and we think we are going to be good for five or six years.”
At the time of the first transfer to the veterans commission last year, Fraker noted how facilities were just “getting up and running now, and the first testing laboratory [was] on track to be operational very soon.”
“We are confident that medical marijuana will become available for patients this month, and I am grateful for all of the hard work by so many that got us to this point,” Fraker said then.
On Thursday, Fraker expressed satisfaction with the latest transfer of funds to the veterans commission.
“Patients are being served by more than 140 dispensary facilities in Missouri now, and we are very pleased to see their sales revenue where it is,” said Fraker. “Ultimately, this is how we are able to provide much-needed funding for the veteran’s commission.”
Paul Kirchhoff, Missouri Veterans Commission (MVC) executive director, commented on how the funds will be utilized.
“MVC will use these funds for veterans’ health and safety initiatives designated in House Bill 8,” said Kirchhof. “A portion of these funds will also be used to complete the Missouri Veterans Cemetery – Jacksonville columbarium wall.”
The post Missouri Transfers Almost $7M in Cannabis Revenue to Veterans appeared first on High Times.
At last 60% of all plastic products in the world are made from polymer resins. Everyday products like plastic bottles are made from the polymer resin known as Polyethylene terephthalate (PET). Hemp plastic is promising, however, the right technology to use in the mass creation of this product is not ready. Advocates for a less polluted world believe that someday in the future, customers would be able to purchase products packaged in 100% hemp-based containers.
Have You Seen This?
Master Grower Certification – Get certified right now using discount code: BWS20 and don’t forget to message me once you complete the course. Happy to help fellow growers, smokers and 420 friendly people IMPROVE their lives. – The AardVark
Latest Blog Posts Of Mine
- What Does the Future Look Like for Non-Smokable Cannabis Products?
- Love Weed But Hate the Munchies? – How to Enjoy Your Cannabis Without the Pizza, Chips, and Twinkies
- How Long Should a Marijuana Tolerance Break Be?
- A Look Inside the Mind of Nora Volkov, The New Head of the National Institute of Drug Abuse
- Better Than a Dispensary? – Excitement Around Cannabis Consumption Lounges Hits a Fever Pitch Across America